Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report

The prognosis of leptomeningeal dissemination of recurrent glioblastoma is poor, and chemotherapy results in minimal palliative efficacy. Temozolomide (TMZ) is an established therapy for patients with malignant glioma and the standard of care in parenchymal gliomas; however, few reports have been pu...

Descripción completa

Detalles Bibliográficos
Autores principales: OKITA, YOSHIKO, NONAKA, MASAHIRO, UMEHARA, TORU, KANEMURA, YONEHIRO, KODAMA, YOSHINORI, MANO, MASAYUKI, NAKAJIMA, SHIN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356381/
https://www.ncbi.nlm.nih.gov/pubmed/25789061
http://dx.doi.org/10.3892/ol.2015.2940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356381/
https://www.ncbi.nlm.nih.gov/pubmed/25789061
http://dx.doi.org/10.3892/ol.2015.2940

Ejemplares similares